Mylan, Apple lose US Supreme Court bids to challenge patent review rule

The U.S. Supreme Court on Tuesday turned back challenges by Apple Inc and drugmaker Mylan Laboratories Ltd to a rule change that made it harder to contest patents before the U.S. Patent and Trademark Office.

The internal rule, adopted in 2020 under former PTO director Andrei Iancu, gives judges at the agency's Patent Trial and Appeal Board greater discretion to reject challenges to the validity of specific patents.

For more information, check out the full story on the link below:

Apple, Mylan lose US SC bids to challenge patent review rule